Autoimmune diseases, immune modulation, inflammation, and self-tolerance
202 articles
New research reveals how immune cells use cysteine for both antioxidant defense and energy production, with major implications for cancer treatment.
Engineered immune cells offer new hope for treating kidney diseases that resist standard therapies, potentially improving long-term health outcomes.
Combining targeted therapies may help patients with severe hidradenitis suppurativa who don't respond to standard treatments.
New targeted therapies and biomarker-driven approaches are revolutionizing RA management, potentially improving healthspan for millions.
New research reveals how rheumatoid arthritis dramatically increases kidney disease risk through inflammation and medication effects.
New research reveals how KLF2 and KLF3 proteins regulate T cell movement and exhaustion, offering insights for immune system optimization.
New research reveals how tissue fibroblasts orchestrate age-related inflammation, creating exhausted T cells that increase vulnerability to disease.
New research reveals how specialized gut cells maintain protective immunity against parasites, offering insights into immune system optimization.
Women with RA using treat-to-target therapy achieved pregnancy 3x faster than those with standard care, with 77% conceiving within one year.
New research explores how pregnancy affects rheumatoid arthritis symptoms and long-term health outcomes for women.
Combining ixekizumab with tirzepatide achieved better joint health and significant weight loss compared to arthritis treatment alone.
Scientists identify key cellular pathways driving lupus, revealing promising new therapeutic targets beyond current treatments.
